Company Filing History:
Years Active: 2016
Title: Mettu Mallikarjuna Rao: Innovator in Anticancer Research
Introduction
Mettu Mallikarjuna Rao is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential applications in cancer treatment.
Latest Patents
Mettu Mallikarjuna Rao holds a patent for "Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors." This invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity, thereby making them useful as anticancer agents.
Career Highlights
Mettu Mallikarjuna Rao is currently associated with Bristol-Myers Squibb Company, where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on developing new therapeutic agents that can effectively combat cancer.
Collaborations
Some of his notable coworkers include Upender Velaparthi and Chetan Padmakar Darne, who have collaborated with him on various projects within the company.
Conclusion
Mettu Mallikarjuna Rao's work exemplifies the impact of innovative research in the fight against cancer. His contributions to medicinal chemistry are paving the way for new therapeutic options that could benefit many patients in the future.